Stock EYEG KIORA PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Kiora Pharmaceuticals, Inc.

Equities

EYEG

US49721T5074

Delayed Nasdaq
Other stock markets
 03:25:18 2024-07-09 pm EDT 		5-day change 1st Jan Change
4.4 USD -0.90% Intraday chart for Kiora Pharmaceuticals, Inc. -0.90% -6.41%
Jul. 02 Kiora Pharmaceuticals, Inc. Announces Board and Committee Changes CI
Jun. 25 Kiora Pharmaceuticals Appoints Roger A. Goldberg to its Scientific Advisory Board CI

Insiders

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Kiora Pharmaceuticals, Inc. Announces Board and Committee Changes
CI
Kiora Pharmaceuticals Appoints Roger A. Goldberg to its Scientific Advisory Board
CI
Kiora Pharmaceuticals, Inc. Announces Board Changes
CI
Kiora Pharmaceuticals, Inc. Appoints Carmine Stengone as an Independent Director
CI
Kiora Pharmaceuticals, Inc. Appoints Melissa Tosca as Executive Vice President of Finance
CI
Kiora Pharmaceuticals, Inc. Announces Brian M. Strem Will Assume Role of its Principal Financial and Accounting Officer
CI
Kiora Pharmaceuticals, Inc. Announces Resignation of Susan L. Drexler as Interim Chief Financial Officer
CI
Kiora Pharmaceuticals, Inc. Appoints Susan L. Drexler as the Principal Accounting Officer and Principal Financial Officer
CI
Kiora Pharmaceuticals, Inc. Announces Executive Changes
CI
First Wave BioPharma Names Sarah Romano as Chief Financial Officer
MT
Kiora Pharmaceuticals, Inc. Appoints Michael Meluzio as Principal Financial Officer and Principal Accounting Officer
CI
Kiora Pharmaceuticals, Inc. Announces Executive Changes
CI
Kiora Pharmaceuticals, Inc. Appoints David Hollander to its Board of Director
CI
EyeGate Pharmaceuticals, Inc. Appoints Eric J. Daniels as Its Chief Development Officer
CI
Eyegate Pharmaceuticals, Inc. Announces Management Changes
CI
Insider Trends: Insider Adds to Selling Trend at EyeGate Pharmaceuticals
MT
EyeGate Pharmaceuticals, Inc. Appoints Brian M. Strem, Ph.D. as President
CI
EyeGate Pharmaceuticals Announces Appointment of Brian M. Strem, as Chief Executive Officer
CI
EyeGate Pharmaceuticals, Inc. Announces Board Changes
CI
EyeGate Pharmaceuticals, Inc. Appoints Franz Obermayr as Acting Chief Executive Officer
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. EYEG Stock
  4. News Kiora Pharmaceuticals, Inc.
  5. Insiders